{"schema_version":"secwatch.filing_event.v1","accession":"0000944809-23-000008","form_type":"8-K","ticker":"OPK","cik":"0000944809","company_name":"OPKO HEALTH, INC.","filed_at":"2023-02-10T23:59:59+00:00","discovered_at":"2026-05-14T18:03:48.669923+00:00","generated_at":"2026-06-19T18:57:25.518910+00:00","sec_items":["1.01","2.03","3.02"],"event_type":"debt","sentiment":"neutral","materiality_score":0.65,"calibrated_materiality_score":0.65,"confidence":"high","headline":"OPKO extends $55M convertible notes maturity to Jan 2025, lowers conversion price to $1.66","bullets":["Original $55M 5% convertible notes due Feb 2023 amended to extend maturity to Jan 31, 2025.","Conversion price reset to $1.66 (10-day VWAP plus 25% premium), down from $5.00 per share.","Interest continues to accrue from last payment date; other terms unchanged.","Notes and shares issuable upon conversion were not registered under Securities Act, relying on Section 4(a)(2) exemption."],"urls":{"canonical":"https://secwatch.observer/filing/0000944809-23-000008","json":"https://secwatch.observer/filing/0000944809-23-000008.json","markdown":"https://secwatch.observer/filing/0000944809-23-000008.md","text":"https://secwatch.observer/filing/0000944809-23-000008.txt","edgar_index":"https://www.sec.gov/Archives/edgar/data/944809/000094480923000008/0000944809-23-000008-index.htm","edgar_primary_document":"https://www.sec.gov/Archives/edgar/data/944809/000094480923000008/opk-20230210.htm"},"model":{"generated_by":"deepseek-v4-flash:cloud@v2","generated_at":"2026-06-19T18:57:25.518910+00:00"},"review":{"review_status":"machine_generated","human_reviewed":false,"corrected":false,"correction_note":null,"correction_timestamp":null,"superseded_by":null,"related_filings":[]},"source_grounded_claims":[{"claim_id":"c89e05be105cc05c873cf9d5e90b6c17e72ef534","claim":"OPKO HEALTH, INC. amended convertible notes at 5% maturing extend the maturity to January 31, 2025.","evidence_excerpt":"On or about February 10, 2023, the Company amended the Notes to extend the maturity to January 31, 2025, and to reset the conversion price to the 10 day volume weighted average price immediately preceding the date of the amended note, plus a 25% conversion premium, or $1.66.","evidence_source":"SEC 8-K Item 2.03/2.04","evidence_url":"https://www.sec.gov/Archives/edgar/data/944809/000094480923000008/0000944809-23-000008-index.htm","confidence":0.9,"family_label":"Debt Financings","details":[{"label":"Instrument","value":"convertible notes"},{"label":"Rate","value":"5%"},{"label":"Maturity","value":"extend the maturity to January 31, 2025"},{"label":"Event","value":"amendment"}],"fact_type":"debt_financing"},{"claim_id":"55c38470e0c35328b7766d1cf859a6be685666b8","claim":"OPKO HEALTH, INC. amended 5% Convertible Promissory Notes with each holder of a Note (effective 2023-02-10).","evidence_excerpt":"On or about February 10, 2023, the Company amended the Notes to extend the maturity to January 31, 2025, and to reset the conversion price to the 10 day volume weighted average price immediately preceding the date of the amended note, plus a 25% conversion premium, or $1.66.","evidence_source":"SEC 8-K Item 1.01/1.02","evidence_url":"https://www.sec.gov/Archives/edgar/data/944809/000094480923000008/0000944809-23-000008-index.htm","confidence":0.9,"family_label":"Material Agreements","details":[{"label":"Action","value":"amendment"},{"label":"Agreement","value":"notes offering"},{"label":"Counterparty","value":"each holder of a Note"},{"label":"Effective","value":"2023-02-10"}],"fact_type":"material_agreement"}],"license":"Source filings: public domain (SEC EDGAR). Summaries (headline + bullets): CC-BY-4.0; attribute https://secwatch.observer"}